Sign Up to like & get
recommendations!
1
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030316
Abstract: Rationale: A remarkable concurrence of an EGFR mutation and an EML4-ALK fusion (double positive) occasionally occurs within a narrow number of patients. Previous studies using targeted therapy on EGFR/ALK co-mutated patients have commonly focused on…
read more here.
Keywords:
lung adenocarcinoma;
alk rearrangement;
alectinib instead;
instead egfr ... See more keywords